Clincosm LogoSign in Get a demo

Ovarian Cancer

Showing NaN - NaN of 94
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma Trial in Chicago, Providence (Nivolumab, Ipilimumab)

Recruiting
  • Ovarian Cancer
  • +4 more
  • Chicago, Illinois
  • +3 more
Jan 26, 2023

Ovarian Cancer, NSCLC, ESCC Trial in United States (ASP0739, Pembrolizumab)

Active, not recruiting
  • Ovarian Cancer
  • +3 more
  • Duarte, California
  • +6 more
Jan 21, 2023

Ovarian Cancer Trial in Worldwide (VS-6766, VS-6766 and Defactinib)

Recruiting
  • Low Grade Ovarian Serous Adenocarcinoma
  • Ovarian Cancer
  • avutometinib (VS-6766)
  • avutometinib (VS-6766) and Defactinib
  • Scottsdale, Arizona
  • +46 more
Dec 29, 2022

Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Tumors Trial in Worldwide (Paclitaxel, Carboplatin, Atezolizumab)

Completed
  • Ovarian Cancer
  • +2 more
  • Phoenix, Arizona
  • +267 more
Nov 7, 2022

Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in United States (REGN5668, Cemiplimab, REGN4018)

Recruiting
  • Ovarian Cancer
  • +2 more
  • Duarte, California
  • +7 more
Sep 26, 2022

Biomarkers in Subjects With Untreated Solid Tumors

Completed
  • Breast Cancer
  • +12 more
  • Blood Sample Collection
  • Phoenix, Arizona
  • +118 more
Aug 31, 2022

Esophageal Tumor, Adenocarcinoma of the Gastroesophageal Junction, GastroEsophageal Cancer Trial in United States (DKN-01)

Available
  • Esophageal Neoplasm
  • +9 more
  • Birmingham, Alabama
  • +3 more
Aug 24, 2022

Breast Cancer, Cholangiocarcinoma, Colorectal Cancer Trial in Worldwide (Entrectinib)

Recruiting
  • Breast Cancer
  • +15 more
  • Goodyear, Arizona
  • +146 more
Aug 24, 2022

Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Tumors Trial in Worldwide (Pembrolizumab, Placebo for pembrolizumab,

Active, not recruiting
  • Ovarian Cancer
  • +2 more
  • Pembrolizumab
  • +7 more
  • Birmingham, Alabama
  • +226 more
Aug 22, 2022

Endometrial Tumors, Ovarian Cancer, Solid Tumor Trial in United States (COM701 in combination with BMS-986207 and nivolumab.)

Recruiting
  • Endometrial Neoplasms
  • +3 more
  • COM701 in combination with BMS-986207 and nivolumab.
  • Chicago, Illinois
  • +8 more
Aug 8, 2022

NSCLC, Renal Cell Cancer, Colorectal Cancer Trial in Australia, United States (CPI-006, CPI-006 + ciforadenant, CPI-006 +

Active, not recruiting
  • Non-Small Cell Lung Cancer
  • +12 more
  • Tucson, Arizona
  • +26 more
Aug 1, 2022

Ovarian Cancer, Breast Cancer, Folic Acid Deficiency Trial in Chicago (Folic Acid Tablet)

Active, not recruiting
  • Ovarian Cancer
  • +2 more
  • Folic Acid Tablet
  • Chicago, Illinois
    Rush University Medical Center
Jul 17, 2022

NSCLC, Ovarian Cancer, Fallopian Tube Cancer Trial in United States (CART-TnMUC1, Cyclophosphamide, Fludarabine)

Active, not recruiting
  • Non-Small Cell Lung Cancer
  • +5 more
  • CART-TnMUC1
  • +2 more
  • Phoenix, Arizona
  • +9 more
Jul 18, 2022

Advanced or Metastatic Solid Tumors, Ovarian Cancer, NSCLC Trial in United States (NC762)

Recruiting
  • Advanced or Metastatic Solid Tumors
  • +3 more
  • New Haven, Connecticut
  • +6 more
Jun 22, 2022

Ovarian Cancer Trial in Worldwide (NovoTTF-100L(O), Paclitaxel)

Active, not recruiting
  • Ovarian Cancer
  • Phoenix, Arizona
  • +118 more
Apr 19, 2022

Advanced Solid Tumors, Head Neck Cancer, Pancreatic Cancer Trial in United States (Cabiralizumab, Nivolumab)

Completed
Has Results
  • Advanced Solid Tumors
  • +6 more
  • Cabiralizumab
  • Nivolumab
  • Scottsdale, Arizona
  • +38 more
Jan 5, 2022

Ovarian Cancer, Fallopian Tubes Cancer, Peritoneal Cancer Trial in United States (Secondary Cytoreductive Surgery, Carboplatin

Active, not recruiting
  • Ovarian Cancer
  • +2 more
  • Secondary Cytoreductive Surgery
  • +2 more
  • Hartford, Connecticut
  • +10 more
Feb 23, 2022

Advanced Cancer, Ovarian Cancer, Breast Cancer Trial in United States (COM701, COM701 with Opdivo (Nivolumab).)

Recruiting
  • Advanced Cancer
  • +9 more
  • COM701
  • COM701 with Opdivo (Nivolumab).
  • Los Angeles, California
  • +10 more
Jan 25, 2022

Ovarian Cancer, Neoadjuvant Chemo, Prehabilitation Trial in Chicago (FIT4SURGERY, Healthy Lifestyle Control)

Recruiting
  • Ovarian Cancer
  • +2 more
  • FIT4SURGERY
  • Healthy Lifestyle Control
  • Chicago, Illinois
    Northwestern University
Jan 4, 2022

Ovarian Cancer, Ovarian Carcinoma, Ovary Cancer Trial in Spain, United States (STRO-002)

Recruiting
  • Ovarian Cancer
  • +6 more
  • Tucson, Arizona
  • +25 more
Dec 20, 2021

Ovarian Tumors, Ovarian Cancer Trial in Canada, United States (Niraparib)

Completed
Has Results
  • Ovarian Neoplasms
  • Ovarian Cancer
  • Chandler, Arizona
  • +54 more
Sep 24, 2021

Gynecologic Cancer, Ovarian Cancer, Endometrial Cancer Trial in Chicago (Group pre-operative counseling)

Completed
  • Gynecologic Cancer
  • +4 more
  • Group pre-operative counseling
  • Chicago, Illinois
    Northwestern University
Aug 13, 2021

Ovarian Cancer Trial in United States (Magrolimab, Avelumab)

Completed
  • Ovarian Cancer
  • Chicago, Illinois
  • +5 more
Jul 26, 2021

Brain Tumor, CNS Tumor, Childhood Germ Cell Tumor Trial in Australia, Canada, United States (sodium thiosulfate, examination)

Completed
Has Results
  • Brain Tumor
  • +8 more
  • sodium thiosulfate
  • examination
  • Birmingham, Alabama
  • +75 more
Jul 1, 2021

Assessment of Paclitaxel-Induced Neuropathy

Active, not recruiting
  • Cancer
  • +2 more
  • Blood Collection
  • Patient Questionnaires
  • Chicago, Illinois
    University of Chicago Comprehensive Cancer Center
Jun 7, 2021